stockrowArrowhead Pharmaceuticals, Inc.
ARWR Healthcare Biotechnology
Arrowhead Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $829.4 million, up 23,258.2% from fiscal 2024.
- Revenue
- +171.0%
- EPS
- −7.94%
- Free cash flow
- −15.4%
- Total debt
- +259.5%
Quarter to June 2026, against a year earlier
Follow ARWR
Alert me
Arrowhead Pharmaceuticals, Inc. (ARWR) Operating cash flow
Arrowhead Pharmaceuticals, Inc.'s operating cash flow for fiscal 2025 was $179.6M, compared with −$462.9M in fiscal 2024. Over the twelve months to 30 June 2026 it was −$59.1M. Over the past ten years it has ranged from −$462.9M (fiscal 2024) to $179.6M (fiscal 2025) — the current reading is the highest in ten years. Arrowhead Pharmaceuticals, Inc. ranks 370th of 603 Biotechnology companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $179.6M | — |
| FY2024 | −$462.9M | — |
| FY2023 | −$153.9M | — |
| FY2022 | −$136.1M | — |
| FY2021 | $171.3M | — |
| FY2020 | −$95.8M | — |
| FY2019 | $173.0M | — |
| FY2018 | −$47.2M | — |
| FY2017 | −$23.9M | — |
| FY2016 | −$64.4M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | −$177.5M | — |
| Mar 2026 | $84.4M | 526.38% |
| Dec 2025 | $13.5M | (34.21%) |
| Sep 2025 | $20.5M | — |
| 42 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| KRYS Krystal Biotech, Inc. compare | $323.9M |
| CORT Corcept Therapeutics Incorporated compare | $198.1M |
| PTGX Protagonist Therapeutics, Inc. compare | $131.2M |
| CAI Caris Life Sciences,�Inc. compare | $83.9M |
| TWST Twist Bioscience Corporation compare | −$53.1M |
| ARWR Arrowhead Pharmaceuticals, Inc. | −$59.1M |
| MDGL Madrigal Pharmaceuticals, Inc. compare | −$157.0M |
| SYRE Spyre Therapeutics, Inc. compare | −$249.3M |
| CYTK Cytokinetics, Incorporated compare | −$572.0M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on ARWR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- The full statement